BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6411443)

  • 1. [Immunogenetics of myasthenia gravis].
    Toyka KV; Hohlfeld R; Hömberg V; Grosse-Wilde H
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1453. PubMed ID: 6411443
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular immunopathogenesis of experimental autoimmune myasthenia gravis.
    Christadoss P; Shenoy M
    Reg Immunol; 1992; 4(5):314-20. PubMed ID: 1337839
    [No Abstract]   [Full Text] [Related]  

  • 3. Possible role of HLA-B8 antigen as a genetic marker of autoimmune thrombocytopenia in a patient with myasthenia gravis.
    Remuzzi G; Misiani R; Livio M; dall'Olio A; Donati MB; de Gaetano G
    Thromb Haemost; 1977 Aug; 38(2):593-4. PubMed ID: 413208
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of thymic pathology with HLA in myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    Clin Immunol; 1999 Jun; 91(3):296-301. PubMed ID: 10370374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of autoimmune myasthenia gravis: the multifaceted contribution of the HLA complex.
    Vandiedonck C; Giraud M; Garchon HJ
    J Autoimmun; 2005; 25 Suppl():6-11. PubMed ID: 16260117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of major histocompatibility complex genes in myasthenia gravis and experimental autoimmune myasthenia gravis pathogenesis.
    Kaul R; Shenoy M; Christadoss P
    Adv Neuroimmunol; 1994; 4(4):387-402. PubMed ID: 7536602
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
    Scherbaum WA; Schumm F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Penicillamine-induced myasthenia gravis].
    Dtsch Med Wochenschr; 1983 Sep; 108(39):1499. PubMed ID: 6578008
    [No Abstract]   [Full Text] [Related]  

  • 9. The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models.
    Tournier-Lasserve E; Bach JF
    J Neuroimmunol; 1993 Sep; 47(2):103-14. PubMed ID: 8370764
    [No Abstract]   [Full Text] [Related]  

  • 10. Major histocompatibility complex class II gene disruption prevents experimental autoimmune myasthenia gravis.
    Kaul R; Shenoy M; Goluszko E; Christadoss P
    J Immunol; 1994 Mar; 152(6):3152-7. PubMed ID: 8144909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of immune response by MHC-linked genes.
    David CS
    Transplant Proc; 1980 Mar; 12(1):8-11. PubMed ID: 6768180
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular immunopathogenesis of myasthenia gravis using MHC class II mutant and transgenic mice.
    Shenoy M; David C; Oshima M; Atassi MZ; Christadoss P
    Ann N Y Acad Sci; 1993 Jun; 681():329-31. PubMed ID: 8395148
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients.
    Djabiri F; Caillat-Zucman S; Gajdos P; Jaïs JP; Gomez L; Khalil I; Charron D; Bach JF; Garchon HJ
    J Autoimmun; 1997 Aug; 10(4):407-13. PubMed ID: 9237805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.
    Shinomiya N; Nomura Y; Segawa M
    Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism at the HLA-DQ locus determines susceptibility to experimental autoimmune myasthenia gravis.
    Raju R; Zhan WZ; Karachunski P; Conti-Fine B; Sieck GC; David C
    J Immunol; 1998 May; 160(9):4169-74. PubMed ID: 9574516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial autoimmune myasthenia gravis.
    Tan JH; Ho KH
    Singapore Med J; 2001 Apr; 42(4):178-9. PubMed ID: 11465320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of sex-related and HLA antigen-bound genetic factors in myasthenia gravis].
    Gyódi KE; Szohor A; Onody K; Klein M; Petrányi GG; Hollán Z
    Orv Hetil; 1980 Mar; 121(13):749-53. PubMed ID: 7383652
    [No Abstract]   [Full Text] [Related]  

  • 18. [Familial myasthenia gravis occurring in a mother and her daughter].
    Yoshida T; Takino Y; Yarita H; Asato H; Ishibashi H
    Rinsho Shinkeigaku; 1982 Nov; 22(11):969-71. PubMed ID: 7168935
    [No Abstract]   [Full Text] [Related]  

  • 19. Waldenström's macroglobulinemia and myasthenia gravis.
    Bartoloni C; Scoppetta C; Flamini G; Guidi L; Bartoccioni E; Lambiase M; Gambassi G; Terranova T
    J Clin Lab Immunol; 1981 Nov; 6(3):275-8. PubMed ID: 6802976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic basis for functional recovery in neurologic diseases.
    Steinman L
    Adv Neurol; 1988; 47():255-64. PubMed ID: 3125724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.